Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists - Test2 - elhamkhani - TriplyDB

Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists

Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists

http://www.wikidata.org/entity/Q37212309

about

Phospholipid--driven gene regulation Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)The challenge of developmental therapeutics for adrenocortical carcinoma Endometrial Expression of Steroidogenic Factor 1 Promotes Cystic Glandular Morphogenesis.Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.Steroidogenic factor-1 (SF-1, NR5A1) and human disease Contributions of steroidogenic factor 1 to the transcription landscape of Y1 mouse adrenocortical tumor cells.Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1 Emerging therapy for adrenocortical carcinoma.Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors.Therapy of adrenocortical cancer: present and future.Potent inhibitory effect of the cyclolignan picropodophyllin (PPP) on human adrenocortical carcinoma cells proliferation.Steroidogenic Factor 1 (NR5A1) resides in centrosomes and maintains genomic stability by controlling centrosome homeostasis.Current and emerging therapies for advanced adrenocortical carcinoma.Animal models of adrenocortical tumorigenesis Current and emerging therapeutic options in adrenocortical cancer treatment.Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.Chloroquine alleviates etoposide-induced centrosome amplification by inhibiting CDK2 in adrenocortical tumor cells.Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation.Orphan nuclear receptors as targets for drug development.Adrenocortical carcinoma: a clinician's update.Genetic aspects of adrenocortical tumours and hyperplasias.Steroidogenic factor-1 and human disease Molecular markers and targeted therapies for adrenocortical carcinoma.5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1.Challenges in surgical pathology of adrenocortical tumours.Nuclear Receptor Profiling of Ovarian Granulosa Cell Tumors

P2860

Q26822791-8F770CCE-3C64-44C7-948B-6529C5061AD7 Q27021404-55AD4181-6504-4E4D-88D9-BB76D859DA91 Q27667247-89E0845E-9A6A-4EEE-8228-7CCC4D769EF1 Q28072970-D4F39695-5755-4FCD-9D94-4349A4805126 Q30353001-2B77576B-E2E8-4246-9018-ED0393A1DC85 Q34199703-648AAB41-59A8-4F58-A7A7-5659F3D5C19D Q34669767-C1DCC0F1-7B8D-4B3D-BFC2-C78CB1606F10 Q34671767-6FC49C6D-E3CD-45DC-BCD0-60B85FC3F017 Q35001325-12B10AC6-A922-4FB5-8FF5-4D8968E0A7F9 Q35018399-290E441F-A115-4702-B7D3-316F65B5F499 Q35094565-A99C3D8E-1CC6-438E-8F8A-8F666D779081 Q35232257-329433C6-E27F-4971-9C25-AC4DEA5AF548 Q35232280-6B1C590A-682A-4859-9E68-11B524900593 Q35546340-B433FACA-2D5D-4993-9D2A-23AE0804877E Q35584305-A22082C5-DCA3-49F9-9994-339FFAF61BA1 Q35784857-6865B071-03DB-410C-AB90-D22D44957374 Q36183873-2B37C527-0F3F-45AE-9A34-B5A754A7192B Q36355661-9FBDEA19-56D0-426D-90BE-1BFFA971409E Q36396549-D12A702F-BD00-40F6-BDD1-94B894AAB779 Q37479334-D64EAE1A-DCCB-4C1C-9149-40483BC3941B Q37725708-D20F1EF2-CF72-46F2-A6CD-DDD568616C72 Q37850996-CCF3E971-BBC0-4128-929C-CBA3FEA30E8C Q37999464-4A0A337A-B1CF-40D6-8809-CB74A6C6D91A Q38050355-696E8E8B-562A-4C49-880A-A26606E8C84F Q38168618-C298941C-D008-4536-A4EE-7551F3FBEF19 Q38668953-902B21E4-881C-49BE-B22C-A2EB4769C45D Q39004649-5BA2D1AF-2FD1-454C-A7C0-797302C45522 Q47576824-25126AC1-E6C1-4972-859C-C048AD970E4D Q58433687-C076516C-3197-456B-B8DE-ACBAD2AE51FB

P2860

Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists

http://www.wikidata.org/entity/Q37212309

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of adrenocortical c ...... enic factor-1 inverse agonists

@en

Inhibition of adrenocortical c ...... nic factor-1 inverse agonists.

@nl

type

label

Inhibition of adrenocortical c ...... enic factor-1 inverse agonists

@en

Inhibition of adrenocortical c ...... nic factor-1 inverse agonists.

@nl

prefLabel

Inhibition of adrenocortical c ...... enic factor-1 inverse agonists

@en

Inhibition of adrenocortical c ...... nic factor-1 inverse agonists.

@nl

P1433

Q37212309-037A1EAA-B133-41C3-B6DC-6E6C5ACCB8C2

P1476

Q37212309-DB7868D1-E642-4C04-A165-8442F1DA13EC

P2093

Q37212309-3AAFEE4F-1CD4-4B24-BB82-EF68CB7046B1

Q37212309-3D46A268-84BD-4985-8E50-C33B4BDCA426

Q37212309-5A01398B-E885-46ED-BD86-362B6FB310F9

Q37212309-8A48798F-6132-4C75-8498-21009261E5F3

Q37212309-962302E2-B52F-40C3-85B3-1C9CDFBF90A0

P2860

Q37212309-1D088019-E31E-4441-A413-4838C48C651B

Q37212309-211465F0-2BAF-4FEF-AE03-F34333E24142

Q37212309-22B9EB6C-D236-4B87-9DD7-1B7D391B586F

Q37212309-2D5D7E24-075C-4812-9DC5-110C6BBC59C2

Q37212309-341BC12F-BC5F-4C56-8B21-61350652CA17

Q37212309-3702357D-858D-489C-9FEB-A6C51C3A5614

Q37212309-500F66EC-4C62-444C-82B0-98B4E0B4BF3B

Q37212309-50DB170D-C01C-493F-A3ED-143A20ED6DF2

Q37212309-53D56572-4575-4138-9AF2-B836FA31A67A

Q37212309-54EC8154-422D-40BB-8140-22FBE5F49E0D

P304

Q37212309-DE712A4C-133B-4A32-850E-6F06C627D1EC

P31

Q37212309-834EFD6F-ED01-4152-A700-C97DB9FFAF71

P356

Q37212309-10D3D2F8-0EC2-4F80-8DCE-690B394E70DC

P407

Q37212309-63DBD1C8-029C-4D05-A464-6BB24B10482C

P433

Q37212309-6C5A0334-29A4-4F2D-8B4F-0866AE5C9B16

P478

Q37212309-40560C25-0079-4B99-BD6D-171F3BBBCFC2

P50

Q37212309-47FADE18-3859-4746-8810-FB87977F3AD3

P577

Q37212309-D6351ED4-07B1-472D-A014-83E7ED45499C

P698

Q37212309-5EFF888E-79F1-4568-9480-D72760C3B955

P932

Q37212309-65980D40-F07A-4B4F-8DDB-3870F14FE278

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Inhibition of adrenocortical c ...... enic factor-1 inverse agonists

@en

P2093

Dominique Douguet

http://www.w3.org/2001/XMLSchema#string

Franck Madoux

http://www.w3.org/2001/XMLSchema#string

Julie Cazareth

http://www.w3.org/2001/XMLSchema#string

Mabrouka Doghman

http://www.w3.org/2001/XMLSchema#string

Peter Hodder

http://www.w3.org/2001/XMLSchema#string

P2860

Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids

SF-1 a key player in the development and differentiation of steroidogenic tissues

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Adjuvant mitotane treatment for adrenocortical carcinoma

Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols

Identification of the first synthetic steroidogenic factor 1 inverse agonists: pharmacological modulation of steroidogenic enzymes.

Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening

The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1.

Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.

Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds

P304

2178-2183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-2163

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19318454

http://www.w3.org/2001/XMLSchema#string

P932

2690427

http://www.w3.org/2001/XMLSchema#string